Nxstage Medical Inc
(NXTM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 393,941 | 366,378 | 336,123 | 301,501 | 263,429 |
| Cost of Goods | 225,653 | 214,393 | 204,652 | 185,598 | 160,926 |
| Gross Profit | 168,288 | 151,985 | 131,471 | 115,903 | 102,503 |
| Operating Expenses | 182,792 | 156,663 | 146,752 | 138,688 | 121,227 |
| Operating Income | -13,851 | -4,285 | -14,629 | -22,187 | -17,798 |
| Interest Expense | 756 | 1,000 | 1,115 | 863 | 611 |
| Other Income | -863 | -930 | 561 | -10 | -397 |
| Pre-tax Income | -15,470 | -6,215 | -15,183 | -23,060 | -18,806 |
| Income Tax | -145 | 1,102 | 1,077 | 1,253 | -245 |
| Net Income Continuous | -15,325 | -7,317 | -16,260 | -24,313 | -18,561 |
| Minority Interests | -852 | -2,546 | -918 | -367 | N/A |
| Net Income | $-14,473 | $-4,771 | $-15,342 | $-23,946 | $-18,561 |
| EPS Basic Total Ops | -0.22 | -0.07 | -0.24 | -0.39 | -0.31 |
| EPS Basic Continuous Ops | -0.23 | -0.11 | -0.26 | -0.39 | -0.31 |
| EPS Diluted Total Ops | -0.22 | -0.07 | -0.24 | -0.39 | -0.31 |
| EPS Diluted Continuous Ops | -0.23 | -0.11 | -0.26 | -0.39 | -0.31 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.07 | -0.24 | -0.39 | -0.31 |
| EBITDA(a) | $19,903 | $28,352 | $16,086 | $5,510 | $7,050 |